\begin{table}[htbp]
\centering
\caption{Robustness Checks}
\label{tab:robustness}
\small
\begin{tabular}{lcc}
\hline\hline
 & Log Postpartum & Log Postpartum \\
 & Claims & Providers \\
\hline
Baseline (CS-DiD) & 0.2834** & 0.1108 \\
 & (0.1281) & (0.0682) \\
[4pt]
TWFE + state trends & 0.1962* & 0.0542 \\
 & (0.1006) & (0.0422) \\
[4pt]
Balanced panel (\geq 90\% nonzero) & 0.0028 & \\
 & (0.2213) & \\
[4pt]
Randomization inference $p$-value & [0.198] & \\
[6pt]
\multicolumn{3}{l}{\textit{Placebo outcomes (CS-DiD):}} \\
\quad Antepartum claims & 0.0659 & \\
 & (0.2847) & \\
\quad Delivery claims & 0.0452 & \\
 & (0.2618) & \\
\hline\hline
\end{tabular}
\begin{minipage}{0.85\linewidth}
\vspace{6pt}
\footnotesize
\textit{Notes:} All specifications use log-transformed outcomes. Baseline is the Callaway and Sant'Anna (2021) doubly robust estimator with not-yet-treated controls. TWFE + state trends adds state-specific linear time trends. Balanced panel restricts to states with non-zero postpartum claims in $\geq$90\% of months. RI $p$-value from 1,000 permutations of state treatment assignment. Placebo outcomes should show no effect: antepartum care and delivery are unaffected by the postpartum extension. $^{***}p<0.01$, $^{**}p<0.05$, $^{*}p<0.10$.
\end{minipage}
\end{table}
